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Abstract
Background and objectives Over 35% of patients on maintenance dialysis are readmitted to the hospital within
30 days of hospital discharge. Outpatient dialysis facilities often assume responsibility for readmission preven-
tion. Hospital care and discharge practices may increase readmission risk. We undertook this study to elucidate
risk factors identifiable from hospital-derived data for 30-day readmission among patients on hemodialysis.
Design, setting, participants, & measurements Data were taken from patients on maintenance hemodialysis
discharged fromUniversity of North Carolina Hospitals betweenMay of 2008 and June of 2013 who received in-
patient hemodialysis during their index hospitalizations. Multivariable logistic regression models with 30-day
readmission as the dependent outcome were used to identify readmission risk factors. Models considered
variables available at hospital admission and discharge separately.
Results Among 349 patients, 112 (32.1%) had a 30-day hospital readmission. The discharge (versus admission)
model was more predictive of 30-day readmission. In the discharge model, malignancy comorbid condition
(odds ratio [OR], 2.08; 95% confidence interval [95% CI], 1.04 to 3.11), three or more hospitalizations in the prior
year (OR, 1.97; 95% CI, 1.06 to 3.64),$10 outpatient medications at hospital admission (OR, 1.69; 95% CI, 1.00 to
2.88), catheter vascular access (OR, 1.82; 95% CI, 1.01 to 3.65), outpatient dialysis at a nonuniversity–affiliated
dialysis facility (OR, 3.59; 95%CI, 2.03 to 6.36), intradialytic hypotension (OR, 3.10; 95%CI, 1.45 to 6.61), weekend
discharge day (OR, 1.82; 95% CI, 1.01 to 3.31), and serum albumin,3.3 g/dl (OR, 4.28; 95% CI, 2.37 to 7.73) were
associatedwith higher readmission odds.Adecrease in prescribedmedications fromadmission to discharge (OR,
0.20; 95% CI, 0.08 to 0.51) was associated with lower readmission odds. Findings were robust across different
model–building approaches.
Conclusions Models containing discharge day data had greater predictive capacity of 30-day readmission than
admission models. Identified modifiable readmission risk factors suggest that improved medication education
and improved transitions from hospital to community may potentially reduce readmissions. Studies evaluating
targeted transition programs among patients on dialysis are needed.
Clin J Am Soc Nephrol 11: ccc–ccc, 2016. doi: 10.2215/CJN.11611115
Introduction
United States patients on hemodialysis (HD) have dis-
proportionately high hospitalization and 30-day read-
mission rates compared with the general Medicare
population. In 2012, patients on dialysis had a 35%
30-day readmission rate, almost double that of nondial-
ysis Medicare beneficiaries (1). This high hospital utili-
zation comes at great expense. In 2010, inpatient care
constituted 38% of the $30 billion Medicare budget for
ESRD care (1). The planned introduction of a standard-
ized hospital readmission ratio to the Centers for Med-
icaid and Medicare Services Quality Incentive Program
in payment year 2017 has further sharpened the focus
on readmissions (2).
Undoubtedly, 30-day hospital readmission rates of
patients on dialysis are too high, but evidence regard-
ing modifiable risk factors and effective readmission
prevention strategies is limited. The responsibility of
rehospitalization prevention often falls to the outpatient
dialysis facility. Previous studies have shown that timely,
more frequent, and targeted posthospitalization follow-
up reduces readmissions among patients on dialysis (3,4).
Hospital-based strategies for readmission reduction have
received less scrutiny. Patients on dialysis are at in-
creased risk for in–hospital medication errors, infections,
and hemoglobin and albumin declines, rendering inpa-
tient care and discharge practices relevant to readmission
risk (4–6). Hospital data–derived readmission prediction
models have been developed in nondialysis populations
and are helpful for resource allocation (7,8). Targeted
discharge care coordination programs have been shown
to reduce readmissions in some populations (9). To our
knowledge, hospital–based risk factors for readmissions
among patients on HD have not been evaluated.
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We undertook this study to elucidate risk factors identifi-
able from hospital-derived data for 30-day readmission
among patients on HD. Because risk assessment is often
performed at hospital admission, we sought to investigate
the comparative 30-day readmission risk prediction of a
model generated at admission and a model generated at
hospital discharge.
Materials and Methods
Study Design, Population, and Outcome
This observational cohort study included adult patients
on maintenance HD discharged from University of North
Carolina (UNC) Hospitals (Chapel Hill, NC) between May
1, 2008 and June 27, 2013. UNC Hospitals is a public
academic medical center with .800 inpatient beds and
.35,000 acute discharges per year. Study data were ob-
tained from the Carolina Data Warehouse for Health, a
central data repository containing clinical, research, and
administrative data sourced from the UNC Health Care
System. HD treatment data and complete medications
were not electronically captured before 2014 and are not
available in the database. In–hospital HD treatment data
and hospital admission and discharge medications were
abstracted from the scanned medical record by a trained
abstractionist. A nephrologist (S.L.K.) performed repeat
abstractions for patients with missing data. The principal
investigator (J.E.F.) randomly sampled 15% of abstracted
charts to confirm accuracy. The UNC Institutional Review
Board approved this study.
The cohort consisted of patients discharged from UNC
Hospitals medical and surgical services who met the
following inclusion criteria: (1) age $18 years old, (2)
ESRD designation before index hospital admission, and
(3) receipt of inpatient HD during the index admission.
Exclusion criteria included (1) patients on peritoneal dial-
ysis, (2) observation stays, (3) discharges from psychiatric
or inpatient rehabilitation services, (4) receipt of kidney
transplant during index hospitalization, (5) declaration of
ESRD during index hospitalization, (6) death during index
hospitalization, (7) recovery of kidney function during in-
dex hospitalization, and (8) missing data (medication or
select laboratory). We excluded scheduled readmissions
for vascular access or other planned procedures (deter-
mined by admission history and physical review). We re-
quired at least one in–hospital HD treatment to allow
consideration of HD treatment–related variables for model
inclusion.
Patients were eligible to contribute a single index
admission and 30-day readmission. Multiple admissions
per patient were not considered because of the burden of
chart abstraction associated with data collection from all
hospitalizations during the 5-year period (n=867). We ran-
domly selected each patient’s index admission from all
available admissions during the study period. The study
index date was the index hospitalization discharge date.
The study outcome was rehospitalization at UNC Hospi-
tals within 30 days of index discharge. Because death is a
competing risk for readmission, we confirmed vital status
among patients without 30-day readmissions. Using UNC
Hospitals and outpatient dialysis data, we confirmed vi-
tality of all but three patients.
Predictor Variables
We collected administrative data (demographics, comor-
bidities, and previous health care utilization) and clinical
data (diagnoses, hospital procedures, laboratory results,
and vital signs). Hospitalization primary diagnosis was
determined by inpatient administrative codes. Comorbid
conditions were determined by administrative codes asso-
ciated with prior UNC ambulatory and hospital encounters
and the electronic medical record problem list. Operational
definitions are available in Supplemental Table 1. Admis-
sion vital signs were considered as the first nonmissing
values within 6 hours of admission, and discharge vital
signs were considered as the last nonmissing values in
the 12 hours before discharge. Admission laboratory val-
ues were considered as the first nonmissing values within
12 hours of admission, and discharge laboratory values
were considered as the last nonmissing values in the
24 hours before discharge. Serum albumin (grams per
deciliter) was considered as any value obtained during
the hospitalization. When more than one value was avail-
able, the last albumin level was used. We collected HD
variables from the first in–hospital HD treatment during
the index admission. Considered variables are presented
in Tables 1 and 2. Variables were chosen a priori on the
basis of existing literature and their plausible associations
with outcome (7,10,11).
Statistical Analyses
Data are presented as means and SDs for continuous
variables and frequencies and percentages for categorical
variables. We excluded variables with missing data from
consideration for multivariable model inclusion (dialysis
vintage, pre- and post-HD weights, discharge temperature,
sodium, potassium, hemoglobin, white blood cell count,
and platelet count). Baseline comparisons were made using
chi-squared tests and independent samples t tests on the
basis of distributions.
Prediction models were developed using univariate and
multivariable binary logistic regressions, with 30-day
readmission to UNC Hospitals as the dependent outcome.
Models considered only variables with a univariate
P value ,0.20 and were constructed using backward se-
lection with an elimination threshold of 0.10. Multivari-
able model 1 considered qualifying variables available at
hospital admission. Model 2 considered model 1 variables
and qualifying variables available at hospital discharge.
Model goodness of fit was assessed via Hosmer and
Lemeshow testing. The receiver operating characteristic
curve and the area under the receiver operating charac-
teristic curve (AUC) with 95% confidence intervals (95%
CIs) were derived for each model. Model 1 and 2 AUCs
were tested for equality using the method by DeLong et al.
(12) for calculating the AUC SEM and the difference be-
tween model AUCs. Internal model validation was as-
sessed using bootstrap resampling of the full cohort
with 1000 iterations.
Given the modest sample size, sensitivity analyses
evaluating variable selection and model stability were
performed. First, least absolute shrinkage and selection
operator adapted for logistic regression was used for model
variable selection (13,14). Second, because the primary
analysis considered 14 variables in the setting of 112
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readmission events, analyses using a restricted model–
building approach were performed. In these analyses, var-
iables with univariate P values #0.05 were considered for
model inclusion (n=12 variables). Third, primary hospital-
ization diagnosis, age, sex, race, and primary insurer did
not meet the established univariate significance threshold
in primary or sensitivity analyses. These clinically relevant
variables were tested in expanded logistic models. Fourth,
analyses excluding the three patients who died in the
30-day period after index discharge and thus, were not
eligible for readmission were performed. Results were
analogous to those of the primary analyses and are not
shown. Analyses were performed using STATA 12.0MP
(StataCorp., College Station, TX).
Table 1. Cohort characteristics at index hospitalization admission across 30-day hospital readmission status
Characteristic Total, n=349 With 30-dReadmission, n=112
Without 30-d
Readmission, n=237 P Value
a
Administrative data
Age, yr 0.81
#49 99 (28.4%) 33 (29.5%) 66 (27.8%)
50–59 86 (24.6%) 24 (21.4%) 62 (26.2%)
60–69 94 (26.9%) 31 (27.7%) 63 (26.6%)
$70 70 (20.1%) 24 (21.4%) 46 (19.4%)
Women 163 (46.7%) 50 (44.6%) 113 (47.7%) 0.60
Black 219 (62.7%) 67 (59.8%) 152 (64.1%) 0.44
Marital status 0.47
Single 189 (54.2%) 60 (53.6%) 129 (54.4%)
Married 100 (28.6%) 36 (32.1%) 64 (27.0%)
Otherb 60 (17.2%) 16 (14.3%) 44 (18.6%)
Medicare as primary insurance payer 261 (74.8%) 88 (78.6%) 173 (73.0%) 0.26
Diabetes 132 (37.8%) 45 (40.2%) 87 (36.7%) 0.53
Heart failure 166 (47.6%) 58 (51.8%) 108 (45.6%) 0.28
Arterial diseasec 162 (46.4%) 60 (53.6%) 102 (43.0%) 0.06
Hypertension 249 (71.3%) 84 (75.0%) 165 (69.6%) 0.30
Ischemic stroke 58 (16.6%) 20 (17.9%) 38 (16.0%) 0.67
Malignancy 25 (7.2%) 14 (12.5%) 11 (4.6%) 0.01
Hospital admission data
Hospitalizations in the prior year $3 80 (22.9%) 37 (33.0%) 43 (18.1%) 0.002
Outpatient medications $10 186 (53.3%) 67 (59.8%) 119 (50.2%) 0.05
Outpatient use of warfarin 28 (8.0%) 14 (12.5%) 14 (5.9%) 0.04
Outpatient use of antibiotics 56 (16.1%) 17 (15.2%) 39 (16.5%) 0.76
Outpatient use of narcotics 97 (27.8%) 35 (31.3%) 62 (26.2%) 0.32
Surgery admitting service 86 (24.6%) 35 (31.2%) 51 (21.5%) 0.05
Temperature $37.8°C 18 (5.2%) 6 (5.4%) 12 (5.1%) 0.91
Systolic BP, mmHg 0.10
#110 54 (15.5%) 24 (21.4%) 30 (12.7%)
111–175 236 (67.6%) 71 (63.4%) 165 (69.6%)
$176 59 (16.9%) 17 (15.2%) 42 (17.7%)
Heart rate, bpm 0.52
#60 19 (5.4%) 8 (7.1%) 11 (4.6%)
61–99 294 (84.2%) 91 (81.2%) 203 (85.6%)
$100 36 (10.3%) 13 (11.6%) 23 (9.7%)
Hemodialysis data
Dialysis vintage, yr 0.38
,1 49 (14.0%) 12 (10.7%) 37 (15.6%)
1–5 30 (8.6%) 7 (6.3%) 23 (9.7%)
.5 76 (21.8%) 27 (24.1%) 49 (20.7%)
Missing 194 (55.6%) 66 (58.9%) 128 (54.0%)
Vascular access 0.06
Fistula 161 (46.1%) 44 (39.3%) 117 (49.4%)
Graft 63 (18.0%) 18 (16.1%) 45 (19.0%)
Catheter 125 (35.8%) 50 (44.6%) 75 (31.6%)
Non–UNC–affiliated outpatient
dialysis facility
176 (50.4%) 68 (60.7%) 108 (45.6%) ,0.01
UNC, University of North Carolina.
aSignificance was assessed by chi-squared testing.
bIncludes separated, divorced, and widowed.
cIncludes ischemic heart disease, myocardial infarction, and peripheral vascular disease.
Clin J Am Soc Nephrol 11: ccc–ccc, June, 2016 Hospital Readmissions among Dialysis Patients, Flythe et al. 3
Table 2. Cohort characteristics during hospitalization across 30-day hospital readmission status
Characteristic Total, n=349 With 30-dReadmission, n=112
Without 30-d
Readmission, n=237 P Value
a
Admission laboratory values
Sodium #135 mmol/L 60 (17.2%) 20 (17.9%) 40 (16.9%) 0.82
Potassium, mEq/L 0.22
,4 78 (22.4%) 29 (25.9%) 49 (20.7%)
4–5.4 204 (58.4%) 67 (59.8%) 137 (57.8%)
$5.5 67 (19.2%) 16 (14.3%) 51 (21.5%)
Hemoglobin, g/dl 0.88
,9.5 90 (25.8%) 30 (26.8%) 60 (25.3%)
9.5–12 198 (56.7%) 64 (57.1%) 134 (56.5%)
.12 61 (17.5%) 18 (16.1%) 43 (18.1%)
White blood cell count
.103103 ml
101 (28.9%) 30 (26.8%) 71 (30.0%) 0.54
Platelet count ,150 89 (25.5%) 32 (28.6%) 57 (24.0%) 0.37
First hospital HD treatment data
Pre–HD systolic BP, mmHg 0.87
,120 95 (27.2%) 32 (28.6%) 63 (26.6%)
120–160 190 (54.4%) 61 (54.5%) 129 (54.4%)
.160 64 (18.3%) 19 (17.0%) 45 (19.0%)
Nadir intradialytic systolic
BP ,90 mmHg
50 (14.3%) 22 (19.6%) 28 (11.8%) 0.05
Pre-HD weight, kg 83.3622.2 (n=289) 83.3622.2 (n=96) 83.4619.7 (n=193) 0.48
Post-HD weight, kg 81.9620.8 (n=286) 80.8621.9 (n=95) 82.5620.3 (n=191) 0.26
Ultrafiltration volume, L 1.961.4 1.961.4 2.061.4 0.26
Ultrafiltration volume $3 L 90 (25.8%) 27 (24.1%) 63 (26.6%) 0.62
Hospitalization characteristics
Primary admission diagnosisb 0.81
Cardiovascular 78 (22.3%) 25 (22.3%) 53 (22.4%)
Infection 76 (21.8%) 26 (23.2%) 50 (21.1%)
Other 195 (55.9%) 61 (54.5%) 134 (56.5%)
Length of stay $4 d 209 (59.9%) 69 (61.6%) 140 (59.1%) 0.65
Intensive care unit–level care 117 (33.5%) 40 (35.7%) 77 (32.5%) 0.55
Weekend discharge 73 (20.9%) 28 (25.0%) 45 (19.0%) 0.19
Discharge destinationc 0.30
Home 277 (79.4%) 86 (76.8%) 191 (80.6%)
Nursing facility 58 (16.6%) 23 (20.5%) 35 (14.8%)
Other 14 (4.0%) 3 (2.7%) 11 (4.6%)
Hospitalization medication changes
Medication no. change 0.004
None 42 (12.0%) 18 (16.1%) 24 (10.1%)
Decrease 87 (25.0%) 16 (14.3%) 71 (30.0%)
Increase 220 (63.0%) 78 (69.6%) 142 (59.9%)
Narcotic start 78 (22.4%) 27 (24.1%) 51 (21.5%) 0.59
Antibiotic start 71 (20.3%) 25 (22.3%) 46 (19.4%) 0.53
Warfarin start 20 (5.7%) 4 (3.6%) 16 (6.8%) 0.24
Discharge vital signs
Temperature, °C 0.01
,37.8 319 (91.4%) 95 (84.8%) 224 (94.5%)
$37.8 13 (3.7%) 7 (6.3%) 6 (2.5%)
Missing 17 (4.9%) 10 (8.9%) 7 (3.0%)
Systolic BP, mmHg 0.04
#110 44 (12.6%) 19 (17.0%) 25 (10.6%)
111–175 278 (79.7%) 89 (79.5%) 189 (79.7%)
$176 27 (7.7%) 4 (3.6%) 23 (9.7%)
Heart rate, bpm 0.69
#60 12 (3.6%) 5 (4.7%) 7 (3.1%)
61–99 282 (83.9%) 90 (84.1%) 192 (83.8%)
$100 42 (12.5%) 12 (11.2%) 30 (13.1%)
Discharge laboratory values
Sodium, mmol/L 0.06
#135 78 (22.4%) 33 (29.5%) 45 (19.0%)
.135 230 (65.9%) 67 (59.8%) 163 (68.8%)
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Results
Characteristics of the Cohort
Figure 1 displays the flow diagram of study cohort selec-
tion. During the study period, 583 patients on dialysis had
1753 admissions to medical or surgical services at UNC Hos-
pitals. After selection criteria were applied, 349 index admis-
sions remained. Cohort characteristics at index hospitalization
across 30-day readmission status are displayed in Tables 1
and 2. Of the 349 patients, 163 (46.7%) were women, the
mean age was 57615 years old, and 219 (62.7%) were black.
Approximately one half (49.6%) dialyzed at UNC–affiliated
outpatient dialysis facilities, 125 (35.8%) dialyzed via catheter,
and 261 (74.8%) had Medicare as the primary insurance
payer. The principal index admission diagnosis was cardio-
vascular related in 78 (22.3%) patients and infection related in
76 (21.8%) patients. The median length of index hospitaliza-
tion was 4 days (quartiles 1–3, 3–9 days).
The cumulative 30-day readmission rate was 27.5%.
Considering only the index hospitalization, the 30-day
readmission rate was 32.1%. The median time from index
discharge to 30-day readmission was 10 days (quartiles 1–3,
6–21 days), with 14 (12.5%) patients readmitted within 3
days of discharge and 3 (2.7%) patients readmitted within
2 days of discharge. Of the 78 patients with an index hos-
pitalization primary cardiovascular diagnosis, 25 (32.1%)
had 30-day readmissions, and 60% of these readmissions
were for diagnoses similar to those of the index hospital-
ization. Primary 30-day readmission diagnoses among pa-
tients with cardiovascular and infection index admission
diagnoses are shown in Supplemental Figure 1. Among
other differences, patients with 30-day readmissions
were more likely to have a malignant comorbid condition,
be hospitalized at UNC Hospitals three or more times in
the prior year, dialyze at a non–UNC–affiliated outpatient
dialysis facility, and be admitted to a surgical service com-
pared with patients without readmissions.
Hospital Readmission Predictors
In univariate analyses, malignancy comorbid condition,
three or more hospitalizations in the prior year, use of $10
medications at the time of admission, outpatient use of
warfarin, admission to a surgical service, catheter vascular
access, dialysis at a non–UNC–affiliated facility, admission
systolic BP #110 mmHg, nadir intradialytic systolic BP
,90 mmHg, and serum albumin ,3.3 g/dl were associ-
ated with higher readmission odds (P value #0.05 for all).
Discharge systolic BP $176 mmHg and a decrease in pre-
scribed outpatient medications were associated with lower
readmission odds (P value ,0.05 for both).
Results of the two multivariable logistic regression
models for 30-day readmission are presented in Table 3.
In the admission model (model 1), malignancy comorbid
condition, three or more hospitalizations in the prior year,
admission to a surgical service, catheter vascular access,
dialysis at a non–UNC–affiliated facility, and admitting
systolic BP #110 mmHg were associated with greater
30-day readmission odds (P value ,0.05 for all). Model per-
formance as characterized by the AUC was moderate: 0.68
(95% CI, 0.60 to 0.77).
Consideration of data available at discharge improved
model performance. The discharge model (model 2) AUC
of 0.79 (95% CI, 0.73 to 0.85) was significantly greater than
the admission model AUC (test for equality [12]; P,0.01)
(Figure 2). In model 2, malignancy comorbid condition
(odds ratio [OR], 2.08; 95% CI, 1.04 to 3.11), three or
more hospitalizations in the prior year (OR, 1.97; 95% CI,
Table 2. (Continued)
Characteristic Total, n=349 With 30-dReadmission, n=112
Without 30-d
Readmission, n=237 P Value
a
Missing 41 (11.7%) 12 (10.7%) 29 (12.2%)
Potassium, mEq/L 0.55
,4 67 (19.2%) 18 (16.1%) 49 (20.7%)
4–5.4 219 (62.7%) 76 (67.9%) 143 (60.3%)
$5.5 23 (6.9%) 6 (5.3%) 18 (7.6%)
Missing 39 (11.2%) 12 (10.7%) 27 (11.4%)
Hemoglobin, g/dl 0.94
,9.5 143 (41.0%) 46 (41.1%) 97 (40.9%)
9.5–12 172 (49.3%) 55 (49.1%) 117 (49.4%)
.12 24 (6.9%) 7 (6.2%) 17 (7.2%)
Missing 10 (2.9%) 4 (3.6%) 6 (2.5%)
White blood cell count
.103103 ml
47 (15.3%; n=308) 17 (17.0%; n=100) 30 (14.4%; n=208) 0.56
Platelet count ,150 85 (28.0%; n=304) 37 (37.4%; n=99) 48 (23.4%; n=205) 0.003
Albumin ,3.3 g/dld 213 (61.0%) 86 (76.8%) 127 (53.6%) ,0.001
Values are shown as mean6SD or n (percentage). n=349 unless otherwise noted. HD, hemodialysis.
aSignificance was assessed by chi-squared tests or independent samples t tests depending on data distribution.
bRelevant administrative codes (Supplemental Table 1) in the first position. Each index admission had a single primary admission
diagnosis.
cNursing facility includes skilled nursing facilities, rehabilitation facilities, and long–term care facilities. Other includes home of family
or friends or a temporary housing location.
dAlbuminwas considered any time during the hospitalization.Whenmore than one valuewas available, the last available value during
the hospitalization was selected.
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1.06 to 3.64), $10 outpatient medications at hospital ad-
mission (OR, 1.69; 95% CI, 1.00 to 2.88), catheter vascular
access (OR, 1.82; 95% CI, 1.01 to 3.65), outpatient dialysis
at a nonuniversity–affiliated dialysis facility (OR, 3.59; 95%
CI, 2.03 to 6.36), intradialytic hypotension (OR, 3.10; 95%
CI, 1.45 to 6.61), weekend discharge day (OR, 1.82; 95% CI,
1.01 to 3.31), and serum albumin ,3.3 g/dl (OR, 4.28; 95%
CI, 2.37 to 7.73) were associated with higher readmission
odds. A decrease in prescribed outpatient medications
from admission to discharge (OR, 0.20; 95% CI, 0.08 to
0.51) was associated with lower readmission odds. Model
goodness of fit was adequate (P=0.35). Results of the boot-
strap resampling validation were similar with an AUC of
0.78 (95% CI, 0.70 to 0.90).
To assess whether the readmission risk associated with
outpatient dialysis at nonuniversity facilities was attribut-
able to case mix differences, we compared patients di-
alyzing at university-affiliated clinics with those dialyzing
at nonuniversity-affiliated clinics. University-associated
patients were more likely to have heart failure compared
with nonuniversity-associated patients (P=0.04), but the two
groups were otherwise similar in terms of demographic,
comorbid, and dialysis characteristics (Supplemental Table 2).
Sensitivity Analyses
We performed sensitivity analyses to test the robustness
of our predictive models under different model–building
paradigms. Analyses using least absolute shrinkage and
selection operator for variable selection yielded similar re-
sults to backward selection (Supplemental Table 3). A
more restrictive approach to model building considering
12 (versus 14) variables also produced analogous findings
(Supplemental Table 4). Finally, an expanded multivari-
able model incorporating the clinically important variables
of age, sex, race, primary insurer, and primary admis-
sion diagnosis was also consistent with primary findings
(Supplemental Table 5).
Discussion
To our knowledge, this is the first study investigating
30-day hospital readmission predictors identifiable from
hospital-derived data among patients on maintenance
HD. Our single-center analysis shows that predictive
models with hospital discharge data are more predictive
of readmission than admission-based models. Factors
associated with higher 30-day readmission odds were
malignancy comorbid condition, three or more hospitali-
zations in the prior year, $10 outpatient medications
at hospital admission, catheter vascular access, outpa-
tient dialysis at a nonuniversity–affiliated dialysis facility,
intradialytic hypotension, weekend discharge day, and se-
rum albumin ,3.3 g/dl. A decrease in prescribed medica-
tions from admission to discharge was associated with
lower readmission odds. Our results show the potential
for transition services focused on medication management
and communication between care settings to reduce hos-
pital readmissions.
Prior studies have identified older age, greater comor-
bidity burden, and anemia as risk factors for hospital
readmission among United States patients on dialysis
(15,16). Harel et al. (17) recently reported that older age,
higher comorbidity index, higher prior health care utiliza-
tion, and receipt of mechanical ventilation during hospi-
talization were associated with readmission in Ontario,
Figure 1. | Flow diagram of study cohort patient selection. aPatients discharged from medical or surgical services were considered for cohort
inclusion. Patients were excluded from consideration on the basis of discharge from the inpatient psychiatry service, discharge from the in-
patient rehabilitation service, and discharge from an observation stay before compilation of the 583 patient source cohort.
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Canada. A Dialysis Outcomes and Practice Patterns Study
analysis found that readmissions were more common after
shorter hospital stays (18). Together, these findings under-
score the importance of in-hospital care to readmission
risk. Despite the plausible importance of in-hospital man-
agement to readmission among patients on dialysis, the
burden of rehospitalization prevention typically falls on
the ambulatory dialysis facility. Little attention has been
paid to modifiable hospital risk factors.
We evaluated 30-day readmission risk factors from a
discharging hospital perspective. Our study cohort’s index
readmission rate of 32.1% is on par with the national rate
(1). Consistent with prior studies, we found that greater
health care utilization was associated with greater odds of
readmission. Similarly, factors related to illness burden,
including outpatient medication number and a cancer co-
morbid condition, predicted readmission. Not surpris-
ingly, low serum albumin was a powerful predictor of
30-day readmission. Catheter vascular access and intradia-
lytic hypotension, two important prognostic factors in the
outpatient setting, were also predictive of readmission
(19,20). Intradialytic hypotension is associated with end
organ ischemia of the heart, gut, and brain and plausibly
places patients at risk for conditions leading to hospital
readmission (21–23). However, low BP is often associated
with poor nutritional status, rendering it a potential risk
marker as opposed to a risk factor (20).
Importantly, we identified several potential actionable
readmission risk factors. We found that weekend discharge
day, prescription medication changes, and outpatient HD
at a nonuniversity-affiliated facility were associated with
higher readmission odds. Patient demographic, comorbid,
and dialysis characteristics were similar across patients
dialyzing at nonuniversity- and university-affiliated clin-
ics, suggesting that patient acuity did not explain the
observed difference between clinic types. Although we
cannot account for other practice differences across units,
better communication between care settings is one poten-
tial explanation for the difference in readmission risk across
facility affiliations. Interestingly, we did not observe a
difference in readmission risk among patients discharged
to nursing facilities (versus home), which has been reported
in other populations (24,25). This finding should be evalu-
ated in larger multicenter cohorts. Overall, our observa-
tions that discharge day, medication changes, and affiliation
of outpatient dialysis unit affect readmission risk raise the
possibility that improved communication between hospitals
and dialysis facilities may reduce readmissions.
Prior studies of readmission prevention have focused on
the ambulatory dialysis unit. Posthospitalization hemoglo-
bin monitoring, erythropoietin–stimulating agent dose ad-
justment, and more frequent provider visits have been
shown to reduce readmissions (3,4). Ultimately, hospital
readmission prevention must be a shared responsibility
among the outpatient dialysis facility, the treating nephrol-
ogist, and the discharging hospital. Care transitions across
health care settings represent ideal opportunities to opti-
mize these critical collaborations. Our findings indicate the
potential for redesign of the discharge process to incorpo-
rate clinical pharmacy activities with a focus on medica-
tion regimen consolidation and patient education to be
helpful. Although our analyses showed benefit from
streamlined medication regimens, we cannot exclude the
possibility that this finding may be attributable to less sick
patients requiring fewer medications as opposed to more
effective medication management. However, pharmacy
discharge interventions have proven effective in other
populations, making medication management a potential
target for readmission reduction among patients on dialysis
(26). Hospital discharge day also influenced readmission
risk. Many hospitals, including our own, have reduced
weekend case management services. Additionally, medical
team continuity is often disrupted on weekends. These is-
sues in combination with our finding that patients from
Figure 2. | The areas under the receiver operator characteristic curves (AUCs) for the admission data and discharge data multivariable
logistic regression models for 30-day hospital readmission differed significantly. Prediction models were developed using univariate and
multivariable binary logistic regressions,with 30-day readmission toUniversity of NorthCarolinaHospitals as the dependent outcome.Models
considered only variables with a univariate P value ,0.20 and were constructed using backward selection with an elimination threshold of
0.10. Multivariable model 1 considered qualifying variables available at hospital admission. Model 2 considered model 1 variables and
qualifying variables available at hospital discharge. Models 1 and 2 AUCs were tested for equality using the method by DeLong et al. (12) for
calculating the AUC SEM and the difference between model AUCs. ROC, receiver operating characteristic curve.
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nonuniversity–affiliated dialysis facilities had greater read-
mission odds underscore the critical importance of commu-
nication between hospitals and ambulatory dialysis facilities.
Augmented case management services and formalized infor-
mation transfer across care settings represent feasible oppor-
tunities to possibly improve readmission rates among
patients on dialysis.
Readers must consider our results in the context of study
limitations. First, we used data from a single center. Our
population has a high proportion of black patients, and
.50% of patients receive outpatient HD at university-
affiliated facilities. Also, we considered patients discharged
from medical or surgical services. Our results may not
generalize to other centers and may not generalize to pa-
tients discharged from inpatient psychiatry or rehabilita-
tion services. Our prediction models should be externally
validated. Sample size precluded use of separate develop-
ment and validation cohorts. Second, we did not consider
multiple outcomes per patient. We randomly selected a
single hospitalization as the index hospitalization to facil-
itate data abstraction. However, use of a single index hos-
pitalization is consistent with the operational environment
in which the model will be used. Third, we were unable to
consider readmissions that occurred outside our hospital
network; however, patients dialyzing at UNC-affiliated fa-
cilities typically receive inpatient care from our system.
Fourth, we were not able to consider all variables poten-
tially associated with readmission in prediction model de-
velopment. Unmeasured factors, such as health literacy,
social support, and functional status, may influence read-
mission risk and were not included in the model. How-
ever, these factors are not typically measured in clinical
care, and we sought to develop a prediction model from
routinely available data. Additionally, our sample size was
modest, and our outcome number prevented consideration
of more variables because of model stability concerns. How-
ever, our prediction model AUC was moderately strong,
and the model was robust to multiple model–building ap-
proaches, providing reassurance regarding our findings.
Fifth, because of sample size limitations, we were unable
to perform subgroup analyses to investigate risk factors for
readmission among patients readmitted for diagnoses simi-
lar to index hospitalization primary diagnoses. This impor-
tant subgroup should be considered in future larger studies.
In conclusion, we evaluated risk factors associated with
30-day hospital readmission among patients on mainte-
nance dialysis from the hospital perspective and identified
feasible, relatively low–cost strategies that may potentially
reduce readmissions. Our findings of an association be-
tween 30-day readmission and dialysis at a nonuniver-
sity–affiliated outpatient facility, changes in prescribed
medications, and weekend discharge day raise the possi-
bility that improved communication and care coordination
between the hospital and ambulatory settings may reduce
readmissions. Intervention studies evaluating targeted
transition programs among patients on dialysis are
needed.
Acknowledgments
The authors thank Lauren N. Blazek for her data abstraction
contributions and Julia Wenger for her comments on analyses and
the manuscript draft.
This project was made possible by the North Carolina Trans-
lational andClinical Sciences Institute fundedbyNationalCenter for
Advancing Translational Sciences, National Institutes of Health
grant UL1TR001111.
Disclosures
None.
References
1. US Renal Data System: Atlas of End-Stage Renal Disease in the
United States, Bethesda,MD,National Institutes ofHealth,National
Institute of Diabetes and Digestive and Kidney Diseases, 2013
2. Centers for Medicare andMedicaid Services: ESRDQIP Summary:
Payment Years 2014–2018. Available at: https://www.cms.gov/
Medicare/Quality-Initiatives-Patient-Assessment-Instruments/
ESRDQIP/Downloads/ESRDQIPSummaryPaymentYears2014-
2018.pdf. Accessed December 5, 2015
3. Erickson KF, Winkelmayer WC, Chertow GM, Bhattacharya J:
Physician visits and 30-day hospital readmissions in patients re-
ceiving hemodialysis. J Am Soc Nephrol 25: 2079–2087, 2014
4. Chan KE, Lazarus JM, Wingard RL, Hakim RM: Association be-
tween repeat hospitalization and early intervention in dialysis pa-
tients following hospital discharge. Kidney Int 76: 331–341, 2009
5. Chapin E, Zhan M, Hsu VD, Seliger SL, Walker LD, Fink JC:
Adverse safety events in chronic kidney disease: The frequency of
“multiple hits.” Clin J Am Soc Nephrol 5: 95–101, 2010
6. Hug BL, Witkowski DJ, Sox CM, Keohane CA, Seger DL, Yoon C,
Matheny ME, Bates DW: Occurrence of adverse, often prevent-
able, events in community hospitals involving nephrotoxic drugs
or those excreted by the kidney. Kidney Int 76: 1192–1198, 2009
7. Donze´ J, Aujesky D, Williams D, Schnipper JL: Potentially
avoidable 30-day hospital readmissions in medical patients:
Derivation and validation of a prediction model. JAMA Intern
Med 173: 632–638, 2013
8. Escobar GJ, Ragins A, Scheirer P, Liu V, Robles J, Kipnis P: Non-
elective rehospitalizations and postdischarge mortality: Pre-
dictive models suitable for use in real time. Med Care 53: 916–
923, 2015
9. Hansen LO, Young RS, Hinami K, Leung A, Williams MV: Inter-
ventions to reduce 30-day rehospitalization: A systematic review.
Ann Intern Med 155: 520–528, 2011
10. Gruneir A, Dhalla IA, van Walraven C, Fischer HD, Camacho X,
Rochon PA, Anderson GM: Unplanned readmissions after hos-
pital discharge among patients identified as being at high risk for
readmission using a validated predictive algorithm.OpenMed 5:
e104–e111, 2011
11. Kansagara D, Englander H, Salanitro A, Kagen D, Theobald C,
Freeman M, Kripalani S: Risk prediction models for hospital re-
admission: A systematic review. JAMA 306: 1688–1698, 2011
12. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the
areas under two or more correlated receiver operating charac-
teristic curves: A nonparametric approach. Biometrics 44: 837–
845, 1988
13. TibshiraniR:Regression shrinkageand selectionvia the lasso. J R Stat
Soc Series B (Methodol) 58: 267–288, 1996
14. Hastie T, Tibshirani R, Friedman J: The Elements of Statistical
Learning: Data Mining, Inference, and Prediction, Stanford, CA,
Springer, 2009
15. Powe NR, Griffiths RI, Watson AJ, Anderson GF, de Lissovoy G,
Greer JW, Herbert RJ, Milam RA, Whelton PK: Effect of re-
combinant erythropoietin on hospital admissions, readmissions,
length of stay, and costs of dialysis patients. J Am Soc Nephrol 4:
1455–1465, 1994
16. Xia H, Ebben J, Ma JZ, Collins AJ: Hematocrit levels and hospi-
talization risks in hemodialysis patients. J Am Soc Nephrol 10:
1309–1316, 1999
17. Harel Z, Wald R, McArthur E, Chertow GM, Harel S, Gruneir A,
Fischer HD, Garg AX, Perl J, Nash DM, Silver S, Bell CM: Re-
hospitalizations and emergency department visits after hospital
discharge in patients receiving maintenance hemodialysis. J Am
Soc Nephrol 26: 3141–3150, 2015
18. Lopes AA, Leavey SF,McCullough K, Gillespie B, Bommer J, Canaud
BJ, SaitoA, FukuharaS,HeldPJ, Port FK,YoungEW:Early readmission
Clin J Am Soc Nephrol 11: ccc–ccc, June, 2016 Hospital Readmissions among Dialysis Patients, Flythe et al. 9
and length of hospitalization practices in the Dialysis Outcomes and
Practice Patterns Study (DOPPS). Hemodial Int 8: 287–294, 2004
19. Lacson E Jr.,WangW, Lazarus JM,HakimRM:Change in vascular
access and hospitalization risk in long-term hemodialysis pa-
tients. Clin J Am Soc Nephrol 5: 1996–2003, 2010
20. Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM: Association
of mortality risk with various definitions of intradialytic hypo-
tension. J Am Soc Nephrol 26: 724–734, 2015
21. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-
induced repetitive myocardial injury results in global and seg-
mental reduction in systolic cardiac function. Clin J Am Soc
Nephrol 4: 1925–1931, 2009
22. McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC,
John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ,
Lai KB, Li PK: Circulating endotoxemia: A novel factor in sys-
temic inflammation and cardiovascular disease in chronic kid-
ney disease. Clin J Am Soc Nephrol 6: 133–141, 2011
23. EldehniMT,McIntyre CW: Are there neurological consequences of
recurrent intradialytic hypotension? SeminDial 25: 253–256, 2012
24. Bjerkreim AT, Thomassen L, Waje-Andreassen U, Selvik HA,
Næss H: Hospital readmission after intracerebral hemorrhage.
J Stroke Cerebrovasc Dis 25: 157–162, 2016
25. Heyes GJ, Tucker A, Marley D, Foster A: Predictors for read-
mission up to 1 year following hip fracture. Arch Trauma Res 4:
e27123, 2015
26. Carter JA, Carr LS, Collins J, Doyle Petrongolo J, Hall K, Murray J,
Smith J, Tata LA: STAAR: Improving the reliability of care co-
ordination and reducing hospital readmissions in an academic
medical centre. BMJ Innov 1: 75–80, 2015
Received: November 2, 2015 Accepted: February 23, 2016
Published online ahead of print. Publication date available at www.
cjasn.org.
This article contains supplemental material online at http://cjasn.
asnjournals.org/lookup/suppl/doi:10.2215/CJN.11611115/-/
DCSupplemental.
10 Clinical Journal of the American Society of Nephrology
